Sign in
Taking people in United StatesPhase 3

Saline Versus Balanced Crystalloid in Traumatic Brain Injury

Key facts

Who runs it
University of Louisville
Where
Louisville, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 3
People taking part
600 people, planned
Started
1 Jun 2025
Expected to end
Sept 2029
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Normal Saline (0.9% NaCl)
  • balanced crystalloid
Record updated
26 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (8)Hide the full registry criteria

Who can take part

  • Trauma patients presenting to the Emergency Room for initial care
  • Glasgow Coma Scale ≤ 12
  • Head CT with skull fracture(s) and/or hemorrhage(s) (>1cm in any single dimension) with a reported mechanism of trauma

Who cannot take part

  • Severe visceral trauma dictating mortality (visceral injury severity score > brain injury severity score)
  • Non-survivable brain injury based on the treating physician's judgment
  • Emergent visceral operative intervention before complete trauma assessment
  • Concern for ruptured intracranial vascular malformation
  • Patients who are transferred from another facility

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in United States.

  • University of Louisville HospitalLouisville, United StatesContact: Mechelle Kaufman, BSNTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to determine which crystalloid (saline or balanced) should be used in the critical management of Traumatic Brain Injury (TBI) in moderate or severe TBI patients. This trial will determine whether the use of saline or balanced crystalloids is associated with improved outcomes in TBI patients.

Read full original descriptionShow less

Participants will

1. be given fluids through the veins, either saline or balanced fluid will be given. 2. From the first day to the day 14 of the hospitalization (or discharge, whichever comes first), vital signs, laboratory values, treatments given, and other medical data will be collected from the medical record. 3. Six months later, your final disability, if any, will be assessed during your follow-up with a doctor. It involves answering a short survey that will take about 5 minutes or less.

The 2 groups in the trial

  • Normal SalineTreatment being tested

    normal saline (0.9% sodium chloride) administered intravenously

    Treatment: Normal Saline (0.9% NaCl)

  • Isotonic CrystalloidExisting treatment, for comparison

    balanced crystalloid intravenous fluid therapy

    Treatment: balanced crystalloid

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Saline vs. Balanced Crystalloid in Traumatic Brain Injury
Criteria questions
Built from NCT06953674, who can take part
Record updated
26 August 2026